Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia calls for single assessment body grow:

This article was originally published in Clinica

Executive Summary

Frustrated by the absence of a central system to assess new medical technologies, the government of South Australia has decided to act unilaterally. It has put in place its own sub-committee to assess and regulate new medical technologies and procedures. Its move bears out and supports calls by the industry that there is a need for a single national cost-assessment body (see Clinica No 1148, p 11). The state government's views emerged in its submissions to the productivity commission's study of medtech expenditure in Australia. It says that once a product has gained the approval of the Therapeutic Goods Administration (TGA), and is made available in the private system, the assumption is that it will be made available through the public healthcare system, but with no regard to costs to the system.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054726

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel